| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.771 | 8.798 | 4.263 | 13.251 | 12.666 | 12.265 | 14.363 |
| Total Income - EUR | - | - | - | 5.771 | 8.798 | 4.263 | 13.251 | 12.666 | 12.265 | 14.364 |
| Total Expenses - EUR | - | - | - | 1.748 | 2.670 | 2.566 | 4.952 | 6.179 | 5.071 | 8.924 |
| Gross Profit/Loss - EUR | - | - | - | 4.022 | 6.128 | 1.698 | 8.299 | 6.486 | 7.194 | 5.440 |
| Net Profit/Loss - EUR | - | - | - | 3.860 | 5.863 | 1.576 | 7.899 | 6.163 | 6.101 | 4.431 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Doctor Anbruș S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 44.528 | 42.166 | 40.918 | 39.419 | 60.329 |
| Current Assets | - | - | - | 3.979 | 6.406 | 2.424 | 804 | 1.079 | 1.463 | 1.830 |
| Inventories | - | - | - | 68 | 0 | 142 | 314 | 14 | 73 | 72 |
| Receivables | - | - | - | 197 | 4.137 | 1.964 | 3 | 3 | 0 | 208 |
| Cash | - | - | - | 3.714 | 2.269 | 318 | 488 | 1.063 | 1.391 | 1.550 |
| Shareholders Funds | - | - | - | 464 | 6.317 | 1.757 | 8.000 | 14.189 | 20.246 | 24.564 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.516 | 89 | 45.195 | 34.970 | 27.808 | 20.636 | 37.595 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Doctor Anbruș S.r.l.